title: The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells.
abstract: The melanocyte is a neural crest-derived cell that localizes in humans to several organs including the epidermis, eye, inner ear and leptomeninges. In the skin, melanocytes synthesize and transfer melanin pigments to surrounding keratinocytes, leading to skin pigmentation and protection against solar exposure. We have investigated the process of replicative senescence and accompanying irreversible cell cycle arrest, in melanocytes in culture. As was found in other cell types, progressive telomere shortening appears to trigger replicative senescence in normal melanocytes. In addition, senescence is associated with increased binding of the cyclin-dependent kinase inhibitor (CDK-I) p16(INK4a) to CDK4, down-regulation of cyclin E protein levels (and consequent loss of cyclin E/CDK2 activity), underphosphorylation of the retinoblastoma protein RB and subsequent increased levels of E2F4-RB repressive complexes. In contrast to fibroblasts, however, the CDK-Is p21(Waf-1) and p27(Kip-1) are also down-regulated. These changes appear to be important for replicative senescence because they do not occur in melanocytes that overexpress the catalytic subunit of the enzyme telomerase (hTERT), or in melanomas, which are tumors that originate from melanocytes or melanoblasts. In contrast to unmodified melanocytes, hTERT overexpressing (telomerized) melanocytes displayed telomerase activity, stable telomere lengths and an extended replicative life span. However, telomerized melanocytes show changes in cell cycle regulatory proteins, including increased levels of cyclin E, p21(Waf-1) and p27(Kip-1). Cyclin E, p21(Waf-1) and p27(Kip-1) are also elevated in many primary melanomas, whereas p16(INK4a) is mutated or deleted in many invasive and metastatic melanomas. Thus, the molecular mechanisms leading to melanocyte senescence and transformation differ significantly from fibroblasts. This suggests that different cell types may use different strategies to halt the cell cycle in response to telomere attrition and thus prevent replicative immortality.
authors.affiliation: Huffington Center on Aging and Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza M320, Houston, TX 77030, USA.
authors.forename: D
authors.initials: D
authors.lastname: Bandyopadhyay
authors.forename: N
authors.initials: N
authors.lastname: Timchenko
authors.forename: T
authors.initials: T
authors.lastname: Suwa
authors.forename: P J
authors.initials: PJ
authors.lastname: Hornsby
authors.forename: J
authors.initials: J
authors.lastname: Campisi
authors.forename: E E
authors.initials: EE
authors.lastname: Medrano
mesh_terms: D018797:Cell Cycle Proteins / Q000235:genetics / Q000502:physiology; D002471:Cell Transformation, Neoplastic; D016922:Cellular Senescence / Q000235:genetics / Q000502:physiology*; D004268:DNA-Binding Proteins; D015870:Gene Expression; D006801:Humans; D008544:Melanocytes / Q000166:cytology* / Q000502:physiology; D008954:Models, Biological; D019098:Telomerase / Q000502:physiology; D016615:Telomere / Q000502:physiology
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D019098:Telomerase